Latest filing published 07 Aug 2026 for Levi Strauss & Co. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jill Beraud is a declared insider at 2 companies (board member); the most frequent names are Levi Strauss & Co and Revance Therapeutics, Inc. We count 33 filings; the first trade dates from 25 March 2019 and the latest from 5 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 7 August 2026, reports a share grant in Levi Strauss & Co. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations